OTC · Medical - Instruments & Supplies

EssilorLuxottica S.A. (ESLOY) Stock

$98.62 -1.15% OTC: ESLOY Healthcare

EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. The company specializes in the creation, production, and worldwide distribution of a diverse range of vision products, including ophthalmic lenses, eyewear frames, and sunglasses, catering to markets across North America, Europe, Latin America, Asia, Oceania, and Africa.

Valuation

MetricValue
Price$98.62
Market Cap$90.65B
P/E Ratio31.71
P/B Ratio2.01
P/S Ratio2.69
EPS (TTM)$3.11
52-Week High$186.81
52-Week Low$91.44
Dividend Yield2.35%

Financials & Margins

MetricValue
ROE6.39%
ROA3.83%
ROCE6.91%
Gross Margin60.84%
Operating Margin12.36%
Net Margin8.52%
Debt/Equity0.39
Current Ratio0.89

Annual Financials (USD)

Metric20212022202320242025
Revenue$19.8B$24.5B$25.4B$26.5B$28.5B
Operating Profit$2.3B$3.3B$3.2B$3.4B$3.3B
Net Profit$1.4B$2.2B$2.3B$2.4B$2.2B
EPS$1.63$2.42$2.54$2.57$2.39
Op Margin11.6%13.3%12.5%13.0%11.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$59.4B$60.6B$60.5B$64.3B$63.9B
Total Liabilities$23.5B$22.4B$21.6B$23.3B$24.4B
Cash$1.6B$1.8B$2.6B$2.3B$3.5B
Borrowings$13.0B$12.2B$11.7B$13.2B$14.4B

Latest News

This Contact Lens Stock Looks Ready to Rally Barrons.com · Aug 7, 2026 Italian Family Clashes Over $46 Billion Ray-Ban Fortune Bloomberg · Jul 30, 2026 EssilorLuxottica: Publication of the 2026 Interim Financial Report GlobeNewswire · Jul 29, 2026 AI glasses help propel EssilorLuxottica sales growth AFP · Jul 28, 2026 Ray-Ban Maker EssilorLuxottica’s Sales Growth Slows Despite Smartglasses Boom The Wall Street Journal · Jul 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$4.5B$4.8B$4.9B$4.9B$5.1B
Investing Cash Flow$-9.1B$-4.2B$-3.3B$-5.1B$-4.0B
Financing Cash Flow$-1.2B$-1.8B$-446.0M$-1.6B$-1.4B
Net Cash Flow$-5.4B$-1.3B$598.0M$-307.0M$1.6B
Free Cash Flow$3.5B$3.2B$3.3B$3.4B$3.6B

Valuation & Return Ratios

MetricValue
PEG Ratio9.20
EV / EBITDA13.58
FCF Yield4.88%
Quick Ratio0.59
Interest Coverage10.20
Return 1Y-48.32%
Return 3Y-0.32%
Return 5Y-6.41%

Ownership

Insiders Held0.00%
Institutions Held0.01%
Institutions Float Held0.01%
Institutional HolderSharesReport Date
Motiv8 Investments LLC 292025-12-31
Gamma Investing LLC1,9592026-06-30
Thurston, Springer, Miller, Herd & Titak, Inc. 1072026-06-30
Main Street Group, Ltd 2002026-06-30
Westside Investment Management, Inc.2462026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALCAlcon Inc. $64.11 +1.55% 50.34 $31.27B 0.55%
BLCOBausch + Lomb Corporation $17.30 +0.87% -35.85 $6.18B 0.00%
COOThe Cooper Companies, Inc. $54.37 +0.13% 19.29 $10.60B 0.00%
CZMWYCarl Zeiss Meditec AG $35.36 +0.60% 22.43 $3.10B 1.80%
EYENational Vision Holdings, Inc. $16.68 -0.36% 25.82 $1.34B 0.00%

About EssilorLuxottica S.A.

EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. The company specializes in the creation, production, and worldwide distribution of a diverse range of vision products, including ophthalmic lenses, eyewear frames, and sunglasses, catering to markets across North America, Europe, Latin America, Asia, Oceania, and Africa. Its extensive operations are divided into five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale division is responsible for manufacturing and supplying premium and athletic eyewear to other businesses. Conversely, the Retail segment directly offers luxury and sports eyewear to consumers through its various sales channels. The Lenses and Optical Instruments segment provides a broad spectrum of lenses, such as Varilux progressive lenses, Crizal anti-reflective and anti-smudge coatings, Transitions photochromic lenses (including the Gen 8 series), Eyezen lenses optimized for digital screen use, and Xperio polarized sun lenses, alongside corrective options from Nikon and Kodak. This segment also furnishes optical instruments, including lens edging and mounting equipment for opticians and laboratories, and optometry tools for a variety of professionals and institutions, while also developing online optical sales solutions. The Equipment segment focuses on delivering advanced digital surfacing and lens coating machinery to prescription laboratories, integrated optical chains, and lens manufacturers. Lastly, the Sunglasses and Readers segment encompasses a wide array of non-prescription sunglasses and reading glasses, available under numerous well-known proprietary brands like Foster Grant, Magnivision, and SolarShield, licensed brands such as Reebok, Steve Madden, and Disney, and regional labels including Bolon and Mujosh. To support its expansive business, EssilorLuxottica maintains a substantial network of 490 prescription laboratories and edging-mounting facilities globally. The company formally adopted the name EssilorLuxottica Société anonyme in October 2018, having previously been known as Essilor International Société Anonyme.

EssilorLuxottica S.A. is headquartered in FR.

EssilorLuxottica S.A. (ESLOY) stock trades at $98.62 with a market capitalization of $90.65B. The stock is valued at a price-to-earnings (P/E) ratio of 31.71, price-to-book of 2.01, price-to-sales of 2.69. Over the past 52 weeks the stock has ranged between $91.44 and $186.81, and currently trades 47.2% below its 52-week high. It pays a dividend yielding 2.35%.

On profitability, EssilorLuxottica S.A. generates a return on equity (ROE) of 6.39%, return on capital employed of 6.91%, an operating margin of 12.36%, a net profit margin of 8.52%.

In its most recent fiscal year, EssilorLuxottica S.A. reported annual revenue of $28.5B, net profit of $2.2B, revenue has compounded at 14.6% a year over the last five years, profit at 92.1% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.39 — a conservative balance sheet with little leverage risk, a current ratio of 0.89, total assets of $63.9B, $3.5B in cash and equivalents.

ESLOY has an average daily trading volume of 133,150 shares, a beta of 0.55 (less volatile than the overall market).

Official website: www.essilorluxottica.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides